Antagonists of endothelin receptors
US5703106A · kind A · utility
6Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 1996 |
| Grant date | Dec 30, 1997 |
| Priority date | — |
| Expiry date | Sep 25, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds having pharmacological properties represented by the general formula I ##STR1## processes for the manufacture, pharmaceutical compositions and the use of the compounds of formula I and salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.